Synokem Pharmaceuticals Ltd

Synokem Pharmaceuticals Ltd is a 40-year-old pharmaceutical company based in India, with a focus on manufacturing and marketing allopathic medicines. The company operates from three manufacturing plants in Haridwar and its corporate office is in Delhi. Synokem has four primary business verticals, including contract manufacturing for big customers, self-marketing of brands in India, commercial exports to approximately 30 countries, and institutional/government supplies.

The company has made significant contributions to the healthcare sector, particularly during the COVID-19 pandemic, by developing life-saving drugs like favipiravir and mollupiravir and ensuring their global availability in line with government guidelines. Additionally, Synokem has established the Synokem Foundation, an NGO focused on women's healthcare, child education, and the upliftment of visually impaired and abandoned senior citizens.

Founded in 1983, Synokem Pharmaceuticals operates in the health care, manufacturing, and pharmaceutical industries. Their commitment to better healthcare is encapsulated in their slogan: ISO 9001:2008 WHO & GMP Certified Company - "Committed Towards Better Healthcare".

The company recently secured a Private Equity Round investment on 18 January 2023, with TA Associates as the investor. Synokem's dedication to innovation, global recognition, and impactful societal contributions position it as a compelling opportunity for potential investors in the healthcare and pharmaceutical sectors.